UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PloS one, 2012-02, Vol.7 (2), p.e31900-e31900

2012

Volltextzugriff (PDF)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

International journal of molecular sciences, 2019-11, Vol.20 (22), p.5792

2019

Volltextzugriff (PDF)

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Biomolecules (Basel, Switzerland), 2022-07, Vol.12 (7), p.928

2022

Volltextzugriff (PDF)

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Cancers, 2018-10, Vol.10 (10), p.375

2018

Volltextzugriff (PDF)

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Orphanet journal of rare diseases, 2020-08, Vol.15 (1), p.209-209, Article 209

2020

Volltextzugriff (PDF)

Binding Models of Copper(II) Thiosemicarbazone Complexes with Human Serum Albumin: A Speciation Study

Molecules (Basel, Switzerland), 2021-05, Vol.26 (9), p.2711

2021

Volltextzugriff (PDF)

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

BioMed research international, 2015-01, Vol.2015 (2015), p.1-14

2015

Volltextzugriff (PDF)

Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors

Journal for immunotherapy of cancer, 2017-04, Vol.5 (1), p.37-37, Article 37

2017

Volltextzugriff (PDF)

Tuberous sclerosis complex: a complex case

Cold Spring Harbor molecular case studies, 2022-04, Vol.8 (3), p.1

2022

Volltextzugriff (PDF)

Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors

BMC biology, 2011-10, Vol.9 (1), p.69-69, Article 69

2011

Volltextzugriff (PDF)

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

PloS one, 2016-04, Vol.11 (4), p.e0152584-e0152584

2016

Volltextzugriff (PDF)

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells

PloS one, 2018-05, Vol.13 (5), p.e0197105-e0197105

2018

Volltextzugriff (PDF)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

BioMed research international, 2022, Vol.2022 (1), p.3924400-3924400

2022

Volltextzugriff (PDF)

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

European journal of cancer (1990), 2016-12, Vol.69, p.S141

Koromilas, A

2016

Volltextzugriff (PDF)

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Cancer letters, 2015-07, Vol.363 (2), p.101-107

2015

Volltextzugriff (PDF)

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Iranian journal of allergy, asthma, and immunology, 2023-04, Vol.22 (2), p.190

2023

Volltextzugriff (PDF)

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Cancer letters, 2015-05, Vol.361 (1), p.112-120

2015

Volltextzugriff (PDF)

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Marine drugs, 2021-03, Vol.19 (4), p.193

2021

Volltextzugriff (PDF)

Analysis of TSC2 stop codon variants found in tuberous sclerosis patients

European journal of human genetics : EJHG, 2001-11, Vol.9 (11), p.823-828

2001

Volltextzugriff (PDF)

Cancer cell survival depends on collagen uptake into tumor-associated stroma

Nature communications, 2022-11, Vol.13 (1), p.7078-7078, Article 7078

2022

Volltextzugriff (PDF)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Cell & bioscience, 2020-03, Vol.10 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

PloS one, 2021-04, Vol.16 (4), p.e0248380-e0248380

2021

Volltextzugriff (PDF)

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

Biomedicines, 2021-07, Vol.9 (8), p.852

2021

Volltextzugriff (PDF)

mTOR Signaling Network in Cell Biology and Human Disease

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16142

2022

Volltextzugriff (PDF)

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

Cancers, 2022-11, Vol.14 (22), p.5520

2022

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

KollektionPublisher site

SpracheDeutsch

ThemaCancer

ThemaProteins

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Englisch
(182)

Erscheinungsjahr

n.n

Thema

12 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex

Binding Models of Copper(II) Thiosemicarbazone Complexes with Human Serum Albumin: A Speciation Study

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis

Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors

Tuberous sclerosis complex: a complex case

Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

Translation initiation factor eIF2a serine 51 phosphorylation couples with the mammalian target of rapamycin (mTOR) to determine cell fate and tumorigenesis under stress

p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice

Analysis of TSC2 stop codon variants found in tuberous sclerosis patients

Cancer cell survival depends on collagen uptake into tumor-associated stroma

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

mTOR Signaling Network in Cell Biology and Human Disease

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

Aktive Filter

Suchergebnisse filtern